Use

This test aids in the diagnosis and screening of Canavan disease, an autosomal recessive neurodegenerative disorder caused by pathogenic variants in the ASPA gene. It is particularly useful for identifying carrier status—approximately 99% of mutations common in individuals of Ashkenazi Jewish heritage and about 60% in other populations—supporting both reproductive decision-making and clinical evaluation.